Rossella Bertulli - Concepedia

Author

Rossella Bertulli

Fondazione IRCCS Istituto Nazionale dei Tumori ORCID

Also Known As

Alice Baggi, Bertulli Rossella, Diego Ottaviani, Nikolaos Diamantis, P. Sandwall, R Bertulli, R. BERTULLI, R. Bertulli, R.M. Bertulli, Raquel Liñan

142

Publications

8.2K

Citations

H-Index

Concepts

All Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori Istituti di Ricovero e Cura a Carattere Scientifico Istituto Ortopedico Rizzoli University of Padua Azienda Ospedaliera Citta' della Salute e della Scienza di Torino

About

Rossella Bertulli is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	21	2K
2	Cell Biology	3	3	376
3	Health Sciences	2	2	39
4	Gastroenterology	2	2	85
5	Immunology	2	2	61

Rossella Bertulli

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
Synovial sarcoma: A retrospective analysis of 271 patients of all ages treated at a single institution Andrea Ferrari, Alessandro Gronchi, Michela Casanova, Cancer	2004	403
Quality of Surgery and Outcome in Extra-Abdominal Aggressive Fibromatosis: A Series of Patients Surgically Treated at a Single Institution Alessandro Gronchi, Paolo G. Casali, Luigi Mariani, Journal of Clinical Oncology	2003	354
Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial Giovanni Grignani, Emanuela Palmerini, Virginia Ferraresi, The Lancet Oncology Surgical OncologyMedicineStandard TreatmentNon-randomised Phase 2Cancer Treatment	2014	328
A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient Elena Tamborini, Lorena Bonadiman, Angela Greco, Gastroenterology New MutationChromatinTumor BiologyChromatin RemodelingCancer Genomics	2004	324
Status of Surgical Margins and Prognosis in Adult Soft Tissue Sarcomas of the Extremities: A Series of Patients Treated at a Single Institution Alessandro Gronchi, Paolo G. Casali, Luigi Mariani, Journal of Clinical Oncology	2004	282
Initial and Late Resistance to Imatinib in Advanced Gastrointestinal Stromal Tumors Are Predicted by Different Prognostic Factors: A European Organisation for Research and Treatment of Cancer–Italian Sarcoma Group–Australasian Gastrointestinal Trials Group Study M. van Glabbeke, Jaap Verweij, Paolo G. Casali, Journal of Clinical Oncology Imatinib DoseEuropean OrganisationDifferent Prognostic FactorsGastrointestinal OncologyMalignant Disease	2005	279
Imatinib mesylate in chordoma Paolo G. Casali, A. Messina, Silvia Stacchiotti, Cancer	2004	268
Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis Alberto Azzarelli, Alessandro Gronchi, Rossella Bertulli, Cancer	2001	251
High-Grade Soft-Tissue Sarcomas: Tumor Response Assessment—Pilot Study to Assess the Correlation between Radiologic and Pathologic Response by Using RECIST and Choi Criteria Silvia Stacchiotti, Paola Collini, A. Messina, Radiology	2009	224
Neoadjuvant Chemotherapy With Methotrexate, Cisplatin, and Doxorubicin With or Without Ifosfamide in Nonmetastatic Osteosarcoma of the Extremity: An Italian Sarcoma Group Trial ISG/OS-1 Stefano Ferrari, Pietro Ruggieri, Graziella Cefalo, Journal of Clinical Oncology	2012	196

Page 1